| Literature DB >> 35494298 |
Jason Lee1,2, Daniel W Griepp1,2, Colin J Burgess2, Brandon Petrone2, Adam D Bitterman2, Randy M Cohn2.
Abstract
Purpose: To analyze the scientific research that formed the basis of the 2019 American Academy of Orthopaedic Surgeons (AAOS) clinical practice guidelines for the management of rotator cuff injuries.Entities:
Year: 2022 PMID: 35494298 PMCID: PMC9042740 DOI: 10.1016/j.asmr.2021.11.017
Source DB: PubMed Journal: Arthrosc Sports Med Rehabil ISSN: 2666-061X
Strong Recommendation Strength Guideline Subcategories
| Guideline Subcategory | Average Years from 2019 | LOE 1 | LOE 2 | RCT | PS | RS | ||
|---|---|---|---|---|---|---|---|---|
| Management of small to medium tears | 2 | 4.50 ± .71 | 283 | 2 | 0 | 2 | ||
| Long-term nonoperative management | 3 | 3.67 ± 1.53 | 372 | 2 | 1 | 2 | 1 | |
| Diagnosis (clinical examination) | 3 | 3.67 ± .58 | 535 | 2 | 1 | 3 | ||
| Diagnosis (imaging) | 11 | 4.45 ± 2.02 | 1055 | 5 | 6 | 1 | 8 | 2 |
| Post-op mobilization timing | 6 | 4.67 ± 1.63 | 535 | 3 | 3 | 6 | ||
| High-grade partial thickness rotator cuff tears | 4 | 5.25 ± 1.50 | 254 | 0 | 4 | 1 | 3 | |
| Prognostic factors (age) | 3 | 4.67 ± 1.53 | 302 | 1 | 2 | 3 | ||
| Prognostic factors (Worker’s Compensation) | ||||||||
| Biological augmentation with platelet-derived products | 6 | 4.33 ± 1.97 | 453 | 5 | 1 | 5 | 1 | |
| Single-row vs double-row repair | 7 | 6.29 ± 2.36 | 517 | 5 | 2 | 7 | ||
| Single-row vs double-row repair retears | 6 | 5.83 ± 2.23 | 449 | 5 | 1 | 6 | ||
| Open vs arthroscopic repairs | 3 | 3.33 ± 2.31 | 473 | 1 | 2 | 3 |
LOE, level of evidence PS, prospective study; ; RCT, randomized controlled trial; RS, retrospective study.
Moderate Recommendation Strength Guideline Subcategories
| Guideline Subcategory | Average Years from 2019 | LOE 1 | LOE 2 | RCT | PS | RS | ||
|---|---|---|---|---|---|---|---|---|
| Operative management | 3 | 4.67 ± .58 | 339 | 1 | 2 | 2 | 1 | |
| Acromioplasty and rotator cuff repair | 4 | 6.25 ± 1.5 | 423 | 2 | 2 | 3 | 1 | |
| Distal clavicle resection | 2 | 6.50 ± 2.12 | 161 | 2 | 2 | |||
| Corticosteroid injections for rotator cuff tears | 4 | 6.50 ± 2.52 | 331 | 3 | 1 | 2 | 2 | |
| Prognostic factors (higher BMI) | 1 | 4.00 ± 0 | 85 | 1 | 1 | |||
| Prognostic factors (comorbidities) | ||||||||
| Prognostic factors (diabetes) | ||||||||
| Prognostic factors (patient expectations) | ||||||||
| Postoperative pain management | 35 | 4.83 ± 2.35 | 2374 | 21 | 14 | 30 | 5 |
BMI, body mass index; LOE, level of evidence; PS, prospective study; RCT, randomized controlled trial; RS, retrospective study.
Journals Cited in Moderate and Strong Recommendation Strength Guideline Subcategories
| Journal | Mean Patients per Study | LOE 1 | LOE 2 | LOE 3 | LOE 4 | 2019 IF | Country | ||
|---|---|---|---|---|---|---|---|---|---|
| 19 | 2273 | 120 | 8 | 7 | 4 | 2.817 | USA | ||
| 18 | 1168 | 65 | 8 | 9 | 1 | 4.325 | USA | ||
| 13 | 1509 | 116 | 9 | 2 | 1 | 1 | 5.810 | USA | |
| 12 | 2375 | 198 | 10 | 1 | 1 | 4.578 | USA | ||
| 9 | 757 | 84 | 6 | 3 | 3.166 | Germany | |||
| 5 | 377 | 75 | 1 | 3 | 1 | 7.931 | USA | ||
| 4 | 454 | 114 | 2 | 2 | 2.021 | Germany | |||
| 4 | 567 | 142 | 2 | 2 | 1.618 | Germany | |||
| 3 | 180 | 60 | 1 | 2 | 4.305 | USA | |||
| 3 | 500 | 167 | 2 | 1 | 4.306 | UK | |||
| 2 | 577 | 289 | 1 | 1 | 2.965 | UK | |||
| 2 | 100 | 50 | 2 | 1.121 | Turkey | ||||
| 2 | 84 | 42 | 1 | 1 | 3.190 | USA | |||
| 2 | 80 | 40 | 2 | 1.720 | UK | ||||
| 2 | 231 | 116 | 1 | 1 | 6.880 | UK | |||
| 2 | 126 | 63 | 2 | 3.280 | Canada | ||||
| 2 | 90 | 45 | 1 | 1 | 1.310 | South Korea | |||
| 2 | 410 | 205 | 1 | 1 | 4.101 | Germany | |||
| 2 | 192 | 96 | 1 | 1 | 2.854 | Germany | |||
| 2 | 194 | 97 | 1 | 1 | 1.628 | Japan | |||
| 2 | 194 | 97 | 1 | 1 | 3.839 | USA | |||
| 2 | 129 | 65 | 1 | 1 | 1.560 | Germany | |||
| 2 | 192 | 96 | 1 | 1 | 1.552 | USA |
IF, impact factor; LOE, level of evidence.
Journals Cited in Strong Recommendation Strength Guideline Subcategories
| Journal | Mean Patients per Study | LOE 1 | LOE 2 | 2019 IF | Country | ||
|---|---|---|---|---|---|---|---|
| 11 | 1614 | 147 | 5 | 3 | 2.817 | USA | |
| 10 | 1259 | 126 | 7 | 1 | 5.810 | USA | |
| 7 | 462 | 66 | 2 | 5 | 4.325 | USA | |
| 6 | 1724 | 287 | 6 | 4.578 | USA | ||
| 5 | 377 | 75 | 1 | 3 | 7.931 | USA | |
| 4 | 567 | 142 | 2 | 1.618 | Germany | ||
| 3 | 371 | 124 | 1 | 2.021 | Germany | ||
| 3 | 360 | 120 | 1 | 2 | 3.166 | Germany | |
| 2 | 100 | 50 | 2 | 1.121 | Turkey | ||
| 2 | 84 | 42 | 1 | 1 | 3.190 | USA | |
| 2 | 410 | 205 | 1 | 1 | 4.101 | Germany | |
| 2 | 192 | 96 | 1 | 1 | 2.854 | Germany | |
| 2 | 341 | 171 | 1 | 1 | 4.306 | UK |
IF, impact factor; LOE, level of evidence.
Journals Cited in Moderate Recommendation Strength Guideline Subcategories
| Journal | Mean Patients per Study | LOE 1 | LOE 2 | 2019 IF | Country | ||
|---|---|---|---|---|---|---|---|
| 11 | 706 | 64 | 6 | 4 | 4.325 | USA | |
| 9 | 813 | 90 | 3 | 4 | 2.817 | USA | |
| 7 | 754 | 108 | 5 | 1 | 4.578 | USA | |
| 6 | 397 | 66 | 5 | 1 | 3.166 | Germany | |
| 5 | 898 | 180 | 2 | 1 | 5.810 | USA | |
| 3 | 180 | 60 | 1 | 2 | 4.305 | USA | |
| 2 | 80 | 40 | 2 | 1.720 | UK | ||
| 2 | 231 | 116 | 1 | 1 | 6.880 | UK | |
| 2 | 126 | 63 | 2 | 3.280 | Canada | ||
| 2 | 90 | 45 | 1 | 1 | 1.310 | South Korea | |
| 2 | 194 | 97 | 1 | 1 | 1.628 | Japan |
IF, impact factor; LOE, level of evidence.